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The identification of 3-phosphoinositide-dependent
kinase 1 (PDK1) as one of the elusive 70 kDa S6 kinase
kinases has filled a gap in the signaling pathway by
which extracellular receptors regulate translation. Will it
cause us to reconsider the relationships between
previously identified members of the pathway?
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To promote cell division effectively, mitogens must
upregulate translation. Phorbol esters, growth factors,
cytokines and oncogene products all signal to the transla-
tional machinery, calling for increased translation. One of
the master translational switches upon which these signals
converge is the 70 kDa S6 kinase (p70S6K) [1]. Phosphory-
lation of the ribosomal subunit S6 by p70S6K correlates
with increased translation, especially of mRNAs contain-
ing a polypyrimidine tract in their 5′ untranslated regions
[2]. This family of mRNAs includes members thought to
be important for cell-cycle progression. The prominent
role of p70S6K in mitogenesis may thus be due, at least in
part, to its ability to promote the general translation neces-
sary for growth and division, and to generate specifically
many of the molecules necessary for driving the cell cycle.
Inactivation of p70S6K, either by injection of neutralizing
antibodies [3] or by treatment with the natural product
rapamycin [1], has the opposite effect, causing G1 cell-
cycle arrest in many cell types.
The kinase p70S6K was identified and cloned nearly a
decade ago. In the years since then, many of the details of
p70S6K activation have been revealed, including the
identity of potential upstream signaling molecules —
phosphatidylinositol 3-kinase (PI 3-K), protein kinases B
and C (PKB and PKC), phospholipase Cγ (PLCγ), Rac1
and Cdc42. Together, these proteins mediate a signaling
pathway distinct from the well-characterized mitogen
activated protein (MAP) kinase pathway [1]. In addition,
at least nine phosphorylation sites on p70S6K have been
mapped, and their roles in the sequential activation of
p70S6K have been studied meticulously. It appears that
activation involves phosphorylation of the proline-directed
sites in the carboxy-terminal tail of p70S6K, followed by
phosphorylation of Thr389 and Ser404, and finally phos-
phorylation of Thr229 to yield a fully active kinase [4].
Despite the importance of these phosphorylation sites,
until very recently none of the kinases that phosphorylate
p70S6K in vivo had been identified. Two recent papers
[5,6] have identified what may be the first of the elusive
S6 kinase kinases — the recently cloned 3-phosphoinosi-
tide-dependent protein kinase 1 (PDK1).
PDK1 was isolated and cloned during the past year on the
basis of its ability to phosphorylate PKB [7,8]. PKB is the
cellular homolog of the protein encoded by the viral onco-
gene v-akt, and has been shown to have roles in serum-
mediated cell survival and insulin-mediated glucose
uptake and glycogen synthesis (reviewed in [9]). PKB’s
principal means of activation seems, like that of p70S6K, to
be through PI 3-K. Both kinases are activated by constitu-
tively active mutants of PI 3-K, and are inhibited by a
dominant-negative form of PI 3-K or small-molecule PI 3-
K inhibitors, such as wortmanin or LY294002 [1,9]. Consis-
tent with the idea that PDK1 activates PKB in response to
PI 3-K activity, PDK1’s ability to phosphorylate and acti-
vate PKB in vitro is highly dependent upon the presence of
phospholipids generated by PI 3-K, either phosphatidyli-
nositol 3,4-bisphosphate (PIP2) or phosphatidylinositol
3,4,5-trisphosphate (PIP3). Adding vesicles containing
these phospholipids to in vitro kinase assays increases
PDK1’s ability to phosphorylate PKB by as much as one
thousandfold [7].
Although PKB and p70S6K differ structurally, their
sequences are remarkably similar in regions surrounding
their most critical phosphorylation sites. The activation
loop phosphorylation sites Thr308 in PKB and Thr229
in p70S6K both lie within the sequence
T(p)FCGTXEY — where (p) is phosphate, X is a non-
conserved residue and other letters follow the single-
letter amino-acid code — and both kinases possess a
critical phosphorylation site immediately carboxy-termi-
nal to the kinase domain, within the motif
FXXFS/T(p)YXA. Prompted by these similarities, Alessi
et al. [5] and Pullen et al. [6] sought to determine
whether PDK1, the enzyme that phosphorylates PKB on
residue Thr308, is also responsible for phosphorylating
the corresponding activation loop of p70S6K.
Using purified, recombinant forms of PDK1 and p70S6K,
Alessi et al. [5] and Pullen et al. [6] demonstrated that
PDK1 specifically phosphorylates p70S6K at residue
Thr229 in vitro. As might have been predicted by
previously defined models of sequential p70S6K activation
[4], this in vitro phosphorylation at Thr229 was most
pronounced when p70S6K had been disinhibited, either by
truncation of its autoinhibitory carboxy-terminal tail [5], or
by mutation of the proline-directed phosphorylation sites
in the carboxy-terminal tail to acidic residues [6]. Substi-
tuting Thr389 with glutamate also increased the extent of
p70S6K phosphorylation by PDK1. In vitro phosphoryla-
tion of Thr229 by PDK1 resulted in increased p70S6K
activity, as assayed by S6 phosphorylation. This activation
was weak [5] or non-existent [6] with wild-type p70S6K,
but was substantial when the disinhibited p70S6K mutants
were used [5,6].
In vivo studies added further credence to the idea that
PDK1 is an S6 kinase kinase. Co-expression of PDK1 and
p70S6K resulted in modest activation of full-length p70S6K
in vivo. Cotransfection of cells with constructs encoding
PDK1 and the disinhibited p70S6K mutants resulted in a
strong increase in p70S6K activity, which could not be
further augmented by insulin and was comparable to the
activation achieved on cotransfection with constructs
encoding p70S6K and activated forms of PI 3-K or PKB
[5,6]. Furthermore, expression of a kinase-dead PDK1
mutant prevented insulin from activating p70S6K [6].
Together, these results suggest that PDK1 lies on the
pathway leading to p70S6K activation.
Because p70S6K and PKB both lie downstream from PI 3-K
and are phosphorylated by PDK1, it might be tempting to
think that PDK1 serves as a point of bifurcation in the
PI 3-K pathway, activating PKB and p70S6K by the same
mechanism in response to PIP2 or PIP3 production
(Figure 1). For such a model to hold, one incongruent
result must be justified. Alessi et al. [5] found that, in con-
trast to phosphorylation of PKB by PDK1, phosphorylation
of p70S6K by PDK1 in vitro is unaffected by the presence
of phospholipids. Phosphorylation of p70S6K by PDK1 was
dependent only upon the state of the autoinhibitory tail
and Thr389 of p70S6K, with phosphorylation occurring most
readily when Thr389 is phosphorylated and the autoin-
hibitory carboxy-terminal tail is phosphorylated or removed.
Because PI 3-K-generated phospholipids do not activate
PDK1’s kinase activity towards p70S6K in vitro, by what
mechanism does PI 3-K achieve activation of p70S6K, and
how does this mechanism differ from that leading to
activation of PKB? Both PKB and PDK1 contain
pleckstrin homology (PH) domains that bind with high
affinity to PIP2 and PIP3. Deletion of the PH domain
from either protein greatly diminishes the extent of PKB
phosphorylation, although deletion of PDK1’s PH
domain does not abolish the lipid-dependence of PDK1-
mediated PKB phosphorylation [7]. These experiments
suggest that PI 3-K-generated phospholipids facilitate
PKB phosphorylation in part by binding to the autoin-
hibitory PH domain of PKB and increasing the access of
PDK1 to Thr308. 
A more prominent effect of the phospholipids appears to
be recruitment of PDK1 and PKB to the membrane (or
lipid vesicles in vitro), where their increased proximity to
one another facilitates phosphorylation. If p70S6K, which
does not possess a PH domain, is also regulated by con-
trolling its proximity to PDK1, it must have some other
means of being recruited to PDK1-containing membranes.
It has been suggested [5] that this may occur through Rac1
and/or Cdc42, members of the Rho family of small
GTPases that localize to membranes through their iso-
prenyl moieties and have been shown to bind to p70S6K
and to be required for its activation in vivo [10]. In the in
vitro kinase assays performed by Alessi et al. [5], such
GTPases would not have been present, preventing local-
ization of p70S6K to the vesicles and rendering PDK1’s
activity insensitive to lipid activation.
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Figure 1
A model depicting how PDK1 may mediate a
mitogen-induced increase in translation. PDK1
activates PKB by phosphorylation at Thr308
when the two proteins are recruited to the
membrane in response to PIP3 production. By
analogy, p70S6K may be activated when
PDK1 phosphorylates it on Thr229 after
recruitment to the membrane, which in the
case of p70S6K may be mediated by active
forms of the small GTPases Rac1 and/or
Cdc42. GSK3, glycogen synthase kinase 3;
GLUT4, glucose transporter 4; FRAP, FK506-
binding protein–rapamycin associated protein.
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Alternative mechanisms of p70S6K activation can be
imagined that do not require membrane recruitment. For
example, PDK1 may be constitutively active, with access
to residue Thr229 of p70S6K being controlled by
phosphorylation of Thr389 or the carboxy-terminal tail by
a different PI 3-K-dependent kinase. Cotransfection of
cells with constructs encoding p70S6K and a deletion
mutant of PDK1 lacking the PH domain, or experiments
that artificially localize p70S6K to the membrane, may
reveal whether p70S6K activation occurs by increasing its
proximity to PDK1 or by some other means. The exis-
tence of a direct link between PDK1 and p70S6K has
raised other questions. For instance, how do activated
forms of PKB, such as myristoylated PKB, activate p70S6K
if the two are on parallel pathways downstream of PDK1?
Is there a feedback loop from PKB which activates PDK1
toward p70S6K, or does PKB activate p70S6K via phospho-
rylation of Thr389? Another possibility is that PKB and
p70S6K associate so that myristoylated PKB recruits p70S6K
to membranes where it can be phosphorylated by PDK1. 
Another intriguing finding is that PDK1 contains a
phosphorylation site within a region similar to its own con-
sensus target sequence [7] (Figure 2). This motif has now
been identified in the activation loop of several members
of the p70S6K signaling pathway, including p70S6K, PKB,
PKC and PDK1 (it is also found in several kinases with no
known link to the pathway). Curiously, a similar motif also
occurs in FRAP, a member of the phosphatidylinositol
kinase (PIK)-related kinase family, outside its kinase
domain and near its carboxy-terminal tail (Figure 2).
FRAP mediates the rapid dephosphorylation and inactiva-
tion of p70S6K induced by rapamycin [11]. Is PDK1
involved in this process? Some evidence suggests that the
principal rapamycin-sensitive site in p70S6K is Thr389,
rather than Thr229 [2]. Furthermore, PKB appears to be
insensitive to rapamycin [12], and Pullen et al. [6] have
now shown that in vitro PDK1 activity is insensitive to
pretreatment with rapamycin. While this evidence argues
against a role for PDK1 in the rapamycin response, the fre-
quent appearance of this motif is difficult to ignore. 
Are all of these proteins with consensus target sequences
physiological PDK1 substrates, or do they share a common
phosphatase that acts at multiple levels to deactivate the
pathway? Perhaps this motif is recognized by a scaffolding
protein that facilitates signaling by bringing components
of the pathway together. Whatever the reason for this
shared phosphorylation motif, it may play a key role in
governing the pathway that links extracellular signals to
translation regulation. Finding answers to these outstand-
ing questions regarding PDK1’s role in p70S6K signaling is
a necessary step toward understanding how cell prolifera-
tion is controlled.
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Figure 2
PDK1 target motifs in members of the p70S6K pathway, grouped to
emphasise points mentioned in the text. In the first four cases, the
sequence occurs in the enzyme’s kinase domain activation loop; in the
case of FRAP, the sequence lies outside of its kinase domain, in a
region of unknown function. Green, residues identical in all five
proteins; blue, residues conserved in all five proteins; pink, residues
identical within a subgroup; yellow, residues conserved within a
subgroup; phosphorylation sites are indicated by an asterisk.
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